AnPac Bio-Medical Science (ANPC) Stock Analysis

What AnPac Bio-Medical Science does

AnPac Bio-Medical Science Co., Ltd. is a biotechnology firm that specializes in developing and commercializing tests designed for the early detection and screening of various cancer types. These diagnostic tools leverage the company's unique Cancer Differentiation Analysis (CDA) technology and associated devices. AnPac Bio primarily provides these solutions to corporate entities and life insurance companies across the People's Republic of China. Additionally, the company extends its offerings to include comprehensive physical examination package services. AnPac Bio was established in 2010 and maintains its main operational base in Lishui, China.

Key metrics

ETFs linked to ANPC

Broad-market and Healthcare sector ETFs an investor holding AnPac Bio-Medical Science is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ANPC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for AnPac Bio-Medical Science?

AnPac Bio-Medical Science trades under the ticker ANPC on NASDAQ.

Which exchange is ANPC listed on?

ANPC is listed on NASDAQ.

What sector does AnPac Bio-Medical Science operate in?

AnPac Bio-Medical Science is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ANPC in a portfolio?

PortView shows ANPC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.